90 related articles for article (PubMed ID: 19691012)
1. Differentiation between thyroidal and ectopic calcitonin secretion in patients with coincidental thyroid nodules and pancreatic tumors - a report of two cases.
Schneider R; Heverhagen AE; Moll R; Bartsch DK; Schlosser K
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):520-3. PubMed ID: 19691012
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
3. Elevated basal calcitonin levels in a patient with a hurthle-cell carcinoma of the thyroid and neuroendocrine differentiation: report of a case.
Munitiz V; Martinez-Barba E; Riquelme J; Rodriguez JM; Piñero A; Parrilla P
Surg Today; 2005; 35(5):404-6. PubMed ID: 15864423
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin immunoreactivity and hypercalcitoninemia in two patients with sporadic, nonfamilial, gastroenteropancreatic neuroendocrine tumors.
McLeod MK; Vinik AI
Surgery; 1992 May; 111(5):484-8. PubMed ID: 1350867
[TBL] [Abstract][Full Text] [Related]
5. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entity.
Schneider R; Waldmann J; Swaid Z; Ramaswamy A; Fendrich V; Bartsch DK; Schlosser K
Pancreas; 2011 Mar; 40(2):213-21. PubMed ID: 21178652
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
[TBL] [Abstract][Full Text] [Related]
8. A single-centre experience with octreotide in the treatment of different hypersecretory syndromes in patients with functional gastroenteropancreatic neuroendocrine tumors.
Berković MC; Altabas V; Herman D; Hrabar D; Goldoni V; Vizner B; Zjacić-Rotkvić V
Coll Antropol; 2007 Jun; 31(2):531-4. PubMed ID: 17847934
[TBL] [Abstract][Full Text] [Related]
9. The use of octreotide in the treatment of medullary thyroid carcinoma.
Frank-Raue K; Ziegler R; Raue F
Horm Metab Res Suppl; 1993; 27():44-7. PubMed ID: 8330871
[TBL] [Abstract][Full Text] [Related]
10. Medullary carcinoma of the thyroid. An update of diagnostic and prognostic factors.
Gautvik KM
Scand J Clin Lab Invest Suppl; 1991; 206():85-92. PubMed ID: 1947764
[TBL] [Abstract][Full Text] [Related]
11. [Can measurement of basal calcitonin replace the pentagastrin test?].
Vestergaard P; Jönsson AL; Christiansen P; Frohnert J
Ugeskr Laeger; 2008 Oct; 170(41):3238-42. PubMed ID: 18940156
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
[TBL] [Abstract][Full Text] [Related]
13. Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer.
Machens A; Hoffmann F; Sekulla C; Dralle H
Endocr Relat Cancer; 2009 Dec; 16(4):1291-8. PubMed ID: 19726541
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic usefulness of the calcitonin secretion induced with pentagastrin in the familial medullary thyroid carcinoma.
González-Villalpando C; Madero A; Peña J; Ramírez R; Szymansky J; Ruiz JE; Zárate A
Arch Invest Med (Mex); 1985; 16(3):237-45. PubMed ID: 2870690
[No Abstract] [Full Text] [Related]
15. Analysis of pentagastrin and calcium as thyrocalcitonin secretagogues in the early diagnosis of medullary carcinoma of the thyroid gland.
Linehan WM; Farrell RE; Cooper CW; Wells SA
Surg Forum; 1977; 28():110-2. PubMed ID: 617389
[No Abstract] [Full Text] [Related]
16. [Useful and limits of the biochemical markers for the diagnosis of thyroid carcinoma].
Colombo P; Locatelli F; Travaglini P
Ann Ital Chir; 2006; 77(3):209-14. PubMed ID: 17137035
[TBL] [Abstract][Full Text] [Related]
17. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
Mirallié E; Iacobone M; Sebag F; Henry JF
Eur J Surg Oncol; 2004 Sep; 30(7):790-5. PubMed ID: 15296996
[TBL] [Abstract][Full Text] [Related]
18. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma.
Wimalawansa SJ
J Bone Miner Res; 1993 Apr; 8(4):467-73. PubMed ID: 8475796
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic approach, genetic screening and prognostic factors of medullary thyroid carcinoma.
Corsello SM; Lovicu RM; Migneco MG; Rufini V; Summaria V
Rays; 2000; 25(2):257-66. PubMed ID: 11370543
[TBL] [Abstract][Full Text] [Related]
20. Serum cholecystokinin and neurotensin during follow-up of pancreas, prostate and medullary thyroid tumors.
Pichon MF; Coquin G; Fauveau C; Rey A
Anticancer Res; 1999; 19(2B):1445-50. PubMed ID: 10365121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
